18:45 - 20:15
Llull Hall

SUs in the treatment of T2DM: a fresh look and new insights

Evening Session

A. Al Zaid (Saudi Arabia)
A. Amod (South Africa)
The place of SUs in guidelines: Why are there differences?
L. Leiter (Canada)
Latest evidence on SUs: what’s new in 2019?
M. Yu (China)
The place of SUs in the evolving landscape of combination therapy
A. Al Zaid (Saudi Arabia), A. Amod (South Africa), L. Leiter (Canada), M. Yu (China)
Panel discussion
L. Leiter (Canada)
Symposium by: